STORM Therapeutics raises $56M from M Ventures, Pfizer Ventures to start Phase 2 trial for cancer drug

STORM Therapeutics raises $56M from M Ventures, Pfizer Ventures to start Phase 2 trial for cancer drug - Tech Sentiments